The benefits of component-resolved diagnosis in diagnostics of peanut allergy
DOI:
https://doi.org/10.12775/JEHS.2022.12.07.068Keywords
allergy, molecular diagnostics of allergy, allergen-specific E antibodies, asIgEAbstract
Introduction: Why can a peanut allergy cause exceptionally severe reactions, but not to everyone? Is there a way to identify patients who might experience these reactions? What is molecular diagnostics of allergy and what are the benefits of diagnosing patients at risk of anaphylaxis after consuming peanuts?
Purpose: The aim of the study is to show the benefits of molecular diagnostics of allergies based on the example of peanut allergy.
Description of the state of knowledge: The diagnosis of peanut allergy is based on the assessment of the clinical presentation. The gold diagnostic standard is to perform a food challenge for suspected allergen. The following tests are helpful in diagnosis: skin tests or determination of allergen-specific E antibodies (asIgE) in blood serum. Until recently, the determination of asIgE concentration was possible only for allergen extracts. A milestone in diagnosing allergies is a serological diagnosis based on allergen molecules. The possibility of testing individual molecules increases the sensitivity and specificity of peanut allergy diagnostics and allows to indicate the risk of anaphylaxis in individual patients.
Summary: Molecular diagnostics in individuals with peanut allergy make it possible to determine the individual patient’s allergy profile and indicate the risk of anaphylaxis. The information obtained with the help of this tool allows for precise therapeutic recommendations for people allergic to peanuts. Such diagnostics is a step towards personalized medicine in allergology.
Keywords: allergy; molecular diagnostics of allergy; allergen-specific E antibodies; asIgE
References
Abrams, E.M., E.S. Chan, and S. Sicherer, Peanut Allergy: New Advances and Ongoing Controversies. Pediatrics, 2020. 145(5).
Burney, P.G., et al., The prevalence and distribution of food sensitization in European adults. Allergy, 2014. 69(3): p. 365-371.
Hoffmann-Sommergruber, K., et al., Molecular Allergology User’s Guide 2.0. 2022, ©John Wiley & Sons A/S. Published by John Wiley & Sons Ltd: The European Academy of Allergy and Clinical Immunology (EAACI).
Samoliński, B., M. Choina, and E. Majsiak, Korzyści jakie przynosi diagnostyka molekularna w rozpoznawaniu i leczeniu alergii. Alergia, 2019. 79(1): p. 33-40.
Majsiak, E., et al., Molecular diagnostics - an innovative diagnostic tool in allergology. Laboratorium Medyczne, 2019. 4: p. 37-42.
Sicherer, S.H. and H.A. Sampson, Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol, 2018. 141(1): p. 41-58.
Kleine-Tebbe J. and Jakob T., Molecular Allergy Diagnostics. Innovation for a Better Patient Management. Springer International Publishing Switzerland, 2017.
Hemmings, O., et al., Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6. J Allergy Clin Immunol, 2020. 146(3): p. 621-630.e5.
Beyer, K., et al., Predictive values of component-specific IgE for the outcome of peanut and hazelnut food challenges in children. Allergy, 2015. 70(1): p. 90-8.
Buczyłko, K. and E. Majsiak, Wybrane reakcje krzyżowe w alergiach górnych dróg oddechowych i pokarmowych. Alergologia Polska - Polish Journal of Allergology, 2017. 4(4): p. 139-145.
Jappe, U., et al., Lipophilic Allergens, Different Modes of Allergen-Lipid Interaction and Their Impact on Asthma and Allergy. Frontiers in Immunology, 2019. 10(122).
Glaumann, S., et al., Anaphylaxis to peanuts in a 16-year-old girl with birch pollen allergy and with monosensitization to Ara h 8. J Allergy Clin Immunol Pract, 2013. 1(6): p. 698-9.
Majsiak, E., et al., Oleosins: A Short Allergy Review. 2021, Springer US: New York, NY. p. 1-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Magdalena Choina, Weronika Gromek, Magdalena Marzęda, Khrystyna Lishchuk-Yakymovych, Emilia Majsiak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 512
Number of citations: 0
